Laura Sandler - Jul 1, 2025 Form 4 Insider Report for Oruka Therapeutics, Inc. (ORKA)

Role
Chief Operating Officer
Signature
/s/ Paul Quinlan, as attorney-in-fact for Laura Sandler
Stock symbol
ORKA
Transactions as of
Jul 1, 2025
Transactions value $
$0
Form type
4
Date filed
7/1/2025, 09:26 PM
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sandler Laura Lee Chief Operating Officer C/O ORUKA THERAPEUTICS, INC., 855 OAK GROVE AVE., SUITE 100, MENLO PARK /s/ Paul Quinlan, as attorney-in-fact for Laura Sandler 2025-07-01 0002075401

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORKA Employee Stock Option (right to buy) Award $0 +25K $0.00 25K Jul 1, 2025 Common Stock 25K $11.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/4 of the underlying shares on July 1, 2026, and as to 1/48 of the underlying shares monthly thereafter.